Hologic Inc (NASDAQ: HOLX) has reported E.P.S. of $0.83 for its third fiscal quarter (ending June 30) versus $-0.16 for the same period a year ago. E.P.S. were $2.95 for the latest four quarters through June 30 versus $1.95 for the same period a year ago.
Recent Price Action
On 7/29/24, Hologic Inc (NASDAQ: HOLX) stock increased 1.3%, closing at $79.64. Moreover, this advance was accompanied by unusually high trading volume at 154% of normal. The stock has performed in line with the market over the last nine months and has risen 2.0% during the last week.
Current PriceTarget Research Rating
HOLX is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Hologic has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Hologic has a poor Appreciation Score of 29 but a slightly positive Power Rating of 64, triggering the Low Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment